Similar articles

• Frequency and long-term impact of myonecrosis after coronary stenting.

  Brener SJ, Ellis SG, Schneider J, Topol EJ. Brener SJ, et al. Eur Heart J. 2002 Jun;23(11):869-76. doi: 10.1053/euhj.2001.2976. Eur Heart J. 2002. PMID: 12042008
• Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents.

  Stankovic G, Chieffo A, Iakovou I, Orlic D, Corvaja N, Sangiorgi G, Airoldi F, Colombo A. Stankovic G, et al. Am J Cardiol. 2004 Jun 1;93(11):1397-401, A9. doi: 10.1016/j.amjcard.2004.02.039. Am J Cardiol. 2004. PMID: 15165923
• Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.

  Mahaffey KW, Roe MT, Kilaru R, French JK, Alexander JH, Berdan LG, Van De Werf F, Simoons ML, Weaver WD, White HD, Lincoff AM, Kleiman NS, Topol EJ, Harrington RA. Mahaffey KW, et al. Am J Cardiol. 2005 Jun 15;95(12):1404-8. doi: 10.1016/j.amjcard.2005.02.005. Am J Cardiol. 2005. PMID: 15950560
• Reperfusion in acute myocardial infarction: current concepts.

  Katritsis D, Karvouni E, Webb-Peploe MM. Katritsis D, et al. Prog Cardiovasc Dis. 2003 May-Jun;45(6):481-92. doi: 10.1053/pcad.2003.12. Prog Cardiovasc Dis. 2003. PMID: 12800129 Review.
• Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.

  Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Bavry AA, et al. Am J Cardiol. 2004 Apr 1;93(7):830-5. doi: 10.1016/j.amjcard.2003.12.019. Am J Cardiol. 2004. PMID: 15050484 Review.